Skip to content

Eating Disorder Prevention Program for Women With T1D

Evaluating an Eating Disorder Prevention Program for Young Women With Type 1 Diabetes

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05264376
Enrollment
55
Registered
2022-03-03
Start date
2022-03-21
Completion date
2023-04-15
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eating Disorders, Type 1 Diabetes

Brief summary

This study aims to test the effectiveness of an evidence-based eating- disorder prevention program specifically targeted for individuals with Type 1 Diabetes (T1D) compared to an educational control group. The Diabetes Body Project (DBP), is an adaptation of the Body Project which is the only eating disorder prevention program to have repeatedly produced effects when evaluated by independent researchers, produced stronger effects than credible alternative interventions, and affected objective outcomes. DBP has been adapted slightly for individuals with T1D who are at ultra-high risk for eating disorders. The study aims to test the effectiveness of the DBP of reducing body image concerns and reducing eating pathology and improving glycemic control.

Interventions

The Diabetes Body Project (DBP) is an adapted version of the Body Project Prevention program designed specifically for individuals with Type 1 Diabetes. DBP consists of six weekly, one-hour long sessions. Group participants complete the exercises from the original Body Project and also new diabetes-specific content, drawn from Olmsted et al. (2002) that is delivered in a dissonance-based interactive format with Socratic questions from group leaders encourage participants to generate their own answers.

We selected a T1D management/Eating disorder psychoeducational comparison condition previously tested (Olmsted et al., 2002) to control for expectancy effects and demand characteristics. To match the Diabetes Body Project, the educational lectures by Dr. Olmsted will be delivered in 6 1-hour blocks. Topics include basic information about the various EDs, complications of ED behaviors, diabetes and body image, effects of dieting on blood glucose, and the risk of complications.

Sponsors

Stanford University
Lead SponsorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Masking description

The research assistant conducting the diagnostic interviews after the end of the prevention program and at 3-month follow-up won't know whether the participant was in the Diabetes Body Project or the educational control group.

Intervention model description

The Diabetes Body Project and educational control are both designed to last six weeks, for one hour each week. They both focus on diabetes-specific health issues as well as generic issues with thin-idealization.

Eligibility

Sex/Gender
FEMALE
Age
15 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

I)female-identifying II) aged 15-30 years old III) diagnosis of T1D for at least a 6-month duration per American Diabetes Association(ADA) criteria who are taking insulin IV) have visited their diabetes care provider in the past year V) body image concerns

Exclusion criteria

I) not female identifying II) not in age range III) does not have a diagnosis of T1D for at least 6 months per ADA criteria who are taking insulin IV) have not visited their diabetes care provider in the past year V) do not report some level of body dissatisfaction

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Time With Blood Sugar in Range as a Measure of Glycemic ControlThree months following the 6-week intervention periodParticipants wore a continuous-glucose monitor for 14 days as well as self-reported A1c levels. The percentage of time that participants had blood sugar in range (70 to 180 mg/dL) is reported.
Eating Disorder SymptomsAssessed at week 6 (post-intervention) and three months following the 6-week intervention periodParticipants completed a diagnostic interview using the semi-structured Eating Disorder Diagnostic Interview (EDDI) was used to assess eating disorder symptoms, including frequency of binge eating, vomiting, laxative/diuretic use, fasting, and excessive exercise, as well as degree of overvaluation of weight/shape, feeling fat, and fear of weight gain. Participants were also asked about distress regarding binge eating, rapid eating, eating until uncomfortably full, eating large quantities of food when not hungry, eating alone because of embarrassment, and feeling disgusted, depressed, or guilty after binge eating. The research assistant administering the interview was blinded to the person's condition. Scores range from 0 to over 100 for the most severe cases. Higher scores indicate higher levels of eating disorder symptoms. Items assessing symptoms in the past month were summed to form a composite.
Body Dissatisfaction (BS)Week 6 (post-intervention) and three months following the 6-week intervention periodAssessed with the 10-item Body Dissatisfaction Scale which assesses dissatisfaction with various body parts. Each item is scored on a scale of 1 = extremely dissatisfied to 6 = extremely satisfied. Item scores were averaged to create an overall score (1 to 6). Lower scores indicate greater body dissatisfaction.
Thin Ideal InternalizationWeek 6 (post-intervention) and three months following the 6-week intervention periodAssessed with the 8-item Ideal-Body Stereotype Scale-Revised which measures pursuit of the thin ideal. Each item is scored on a scale of 1 = strongly disagree to 5 = strongly agree. Item scores were averaged to create an overall score (1 to 5). Higher scores indicate greater belief in the thin-deal.
Diabetes-Specific Eating PathologyWeek 6 (post-intervention) and three months following the 6-week intervention periodAssessed with the 16-item Diabetes Eating Problem Survey-Revised. Each item is assessed on a scale of 0 = Never to 5= Always. Item scores were averaged to create an overall score (0 to 5). Higher scores indicate greater eating pathology specific to individuals with Type 1 Diabetes such as purposefully not taking enough insulin.
Diabetes-Specific DistressWeek 6 (post-intervention) and three months following the 6-week intervention periodAssessed with the 28-item Type 1 Diabetes Distress Scale which measures distress related to diabetes. Each item is assessed on a scale of 1 = Not a Problem to 6 = A Very Serious Problem. Item scores were averaged to create an overall score (1 to 6). High scores indicate greater distress that are related to living with Type 1 Diabetes.
Negative AffectWeek 6 (post-intervention) and three months following the 6-week intervention periodNegative affect will be assessed with the sadness, guilt, and fear/anxiety subscales (totaling 20 items) from the Positive Affect and Negative Affect Scale-Revised. Each item is scored on a scale of 1 = Not at All to 5 = Extremely. Item scores were averaged to create an overall score (1 to 5) Higher scores indicate greater negative affect.
Quality of Life (Well-Being)Week 6 (post-intervention) and three months following the 6-week intervention periodAssessed with the 5-item World Health Organization Well-Being Index that measures health related quality of life. Each item is scored on a scale of 0 = At no Time to 5 = All of the Time. Item scores were averaged to create an overall score (0 to 5). Higher scores indicate greater well-being.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATOREric Stice, PhD

Stanford University

PRINCIPAL_INVESTIGATORKorey Hood, MDPhD

Stanford University

Participant flow

Participants by arm

ArmCount
Diabetes Body Project
Diabetes Body Project: The Diabetes Body Project (DBP) is an adapted version of the Body Project Prevention program designed specifically for individuals with Type 1 Diabetes. DBP consists of six weekly, one-hour long sessions. Group participants complete the exercises from the original Body Project and also new diabetes-specific content, drawn from Olmsted et al. (2002) that is delivered in a dissonance-based interactive format with Socratic questions from group leaders encourage participants to generate their own answers.
30
Educational Control Group
Educational Control: We selected a T1D management/Eating disorder psychoeducational comparison condition previously tested (Olmsted et al., 2002) to control for expectancy effects and demand characteristics. To match the Diabetes Body Project, the educational lectures by Dr. Olmsted will be delivered in 6 1-hour blocks. Topics include basic information about the various EDs, complications of ED behaviors, diabetes and body image, effects of dieting on blood glucose, and the risk of complications.
25
Total55

Baseline characteristics

CharacteristicDiabetes Body ProjectTotalEducational Control Group
Age, Categorical
<=18 years
3 Participants7 Participants4 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
27 Participants48 Participants21 Participants
Body Dissatisfaction (BS)3.66 score on a scale
STANDARD_DEVIATION 0.61
3.57 score on a scale
STANDARD_DEVIATION 0.71
3.46 score on a scale
STANDARD_DEVIATION 0.83
Diabetes Distress2.44 score on a scale
STANDARD_DEVIATION 0.82
2.44 score on a scale
STANDARD_DEVIATION 0.9
2.44 score on a scale
STANDARD_DEVIATION 1.01
Diabetes eating pathology1.34 score on a scale
STANDARD_DEVIATION 0.65
1.38 score on a scale
STANDARD_DEVIATION 0.72
1.43 score on a scale
STANDARD_DEVIATION 0.81
Eating Disorder Symptoms12.83 composite score
STANDARD_DEVIATION 8.65
14.27 composite score
STANDARD_DEVIATION 13.73
16 composite score
STANDARD_DEVIATION 18.12
Education
Associate's Degree
2 Participants3 Participants1 Participants
Education
Bachelor's Degree
14 Participants21 Participants7 Participants
Education
Did Not Disclose
0 Participants1 Participants1 Participants
Education
Grade School
0 Participants1 Participants1 Participants
Education
High School Degree/Equivalent
1 Participants5 Participants4 Participants
Education
Master's Degree
4 Participants7 Participants3 Participants
Education
Ph.D. or Higher
2 Participants2 Participants0 Participants
Education
Some College, no Degree
4 Participants11 Participants7 Participants
Education
Some High School
3 Participants4 Participants1 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants5 Participants3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
28 Participants50 Participants22 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Negative Affect2.15 score on a scale
STANDARD_DEVIATION 0.73
2.25 score on a scale
STANDARD_DEVIATION 0.81
2.38 score on a scale
STANDARD_DEVIATION 0.89
Percentage of Time With Blood Sugar in Range.63 percentage of time
STANDARD_DEVIATION 0.21
0.63 percentage of time
STANDARD_DEVIATION 0.2
.62 percentage of time
STANDARD_DEVIATION 0.19
Quality of Life2.33 score on a scale
STANDARD_DEVIATION 0.99
2.21 score on a scale
STANDARD_DEVIATION 0.99
2.07 score on a scale
STANDARD_DEVIATION 0.99
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
3 Participants6 Participants3 Participants
Race (NIH/OMB)
Black or African American
1 Participants1 Participants0 Participants
Race (NIH/OMB)
More than one race
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants3 Participants3 Participants
Race (NIH/OMB)
White
25 Participants43 Participants18 Participants
Region of Enrollment
United States
30 Participants55 Participants25 Participants
Sex: Female, Male
Female
30 Participants55 Participants25 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants
Thin-Ideal Internalization3.48 score on a scale
STANDARD_DEVIATION 0.52
3.36 score on a scale
STANDARD_DEVIATION 0.65
3.22 score on a scale
STANDARD_DEVIATION 0.77

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 300 / 25
other
Total, other adverse events
0 / 300 / 25
serious
Total, serious adverse events
0 / 300 / 25

Outcome results

Primary

Body Dissatisfaction (BS)

Assessed with the 10-item Body Dissatisfaction Scale which assesses dissatisfaction with various body parts. Each item is scored on a scale of 1 = extremely dissatisfied to 6 = extremely satisfied. Item scores were averaged to create an overall score (1 to 6). Lower scores indicate greater body dissatisfaction.

Time frame: Week 6 (post-intervention) and three months following the 6-week intervention period

ArmMeasureGroupValue (MEAN)Dispersion
Diabetes Body ProjectBody Dissatisfaction (BS)Post-Test (week 6)2.98 score on a scaleStandard Deviation 0.56
Diabetes Body ProjectBody Dissatisfaction (BS)3-Month Post-Test Follow Up3.09 score on a scaleStandard Deviation 0.71
Educational Control GroupBody Dissatisfaction (BS)Post-Test (week 6)3.46 score on a scaleStandard Deviation 0.5
Educational Control GroupBody Dissatisfaction (BS)3-Month Post-Test Follow Up3.29 score on a scaleStandard Deviation 0.7
Primary

Diabetes-Specific Distress

Assessed with the 28-item Type 1 Diabetes Distress Scale which measures distress related to diabetes. Each item is assessed on a scale of 1 = Not a Problem to 6 = A Very Serious Problem. Item scores were averaged to create an overall score (1 to 6). High scores indicate greater distress that are related to living with Type 1 Diabetes.

Time frame: Week 6 (post-intervention) and three months following the 6-week intervention period

ArmMeasureGroupValue (MEAN)Dispersion
Diabetes Body ProjectDiabetes-Specific Distress3-Month Post-Test Follow Up1.92 score on a scaleStandard Deviation 0.96
Diabetes Body ProjectDiabetes-Specific DistressPost-Test (week 6)1.81 score on a scaleStandard Deviation 0.88
Educational Control GroupDiabetes-Specific Distress3-Month Post-Test Follow Up2.18 score on a scaleStandard Deviation 1.22
Educational Control GroupDiabetes-Specific DistressPost-Test (week 6)2.08 score on a scaleStandard Deviation 0.82
Primary

Diabetes-Specific Eating Pathology

Assessed with the 16-item Diabetes Eating Problem Survey-Revised. Each item is assessed on a scale of 0 = Never to 5= Always. Item scores were averaged to create an overall score (0 to 5). Higher scores indicate greater eating pathology specific to individuals with Type 1 Diabetes such as purposefully not taking enough insulin.

Time frame: Week 6 (post-intervention) and three months following the 6-week intervention period

ArmMeasureGroupValue (MEAN)Dispersion
Diabetes Body ProjectDiabetes-Specific Eating PathologyPost-Test (week 6)0.64 score on a scaleStandard Deviation 0.39
Diabetes Body ProjectDiabetes-Specific Eating Pathology3-Month Post-Test Follow Up0.70 score on a scaleStandard Deviation 0.48
Educational Control GroupDiabetes-Specific Eating Pathology3-Month Post-Test Follow Up1.06 score on a scaleStandard Deviation 0.69
Educational Control GroupDiabetes-Specific Eating PathologyPost-Test (week 6)1.02 score on a scaleStandard Deviation 0.44
Primary

Eating Disorder Symptoms

Participants completed a diagnostic interview using the semi-structured Eating Disorder Diagnostic Interview (EDDI) was used to assess eating disorder symptoms, including frequency of binge eating, vomiting, laxative/diuretic use, fasting, and excessive exercise, as well as degree of overvaluation of weight/shape, feeling fat, and fear of weight gain. Participants were also asked about distress regarding binge eating, rapid eating, eating until uncomfortably full, eating large quantities of food when not hungry, eating alone because of embarrassment, and feeling disgusted, depressed, or guilty after binge eating. The research assistant administering the interview was blinded to the person's condition. Scores range from 0 to over 100 for the most severe cases. Higher scores indicate higher levels of eating disorder symptoms. Items assessing symptoms in the past month were summed to form a composite.

Time frame: Assessed at week 6 (post-intervention) and three months following the 6-week intervention period

ArmMeasureGroupValue (MEAN)Dispersion
Diabetes Body ProjectEating Disorder SymptomsPost-Test (week 6)6.50 composite scoreStandard Deviation 8.1
Diabetes Body ProjectEating Disorder Symptoms3-Month Post-Test Follow Up5.82 composite scoreStandard Deviation 7.14
Educational Control GroupEating Disorder SymptomsPost-Test (week 6)11.87 composite scoreStandard Deviation 12.42
Educational Control GroupEating Disorder Symptoms3-Month Post-Test Follow Up12.30 composite scoreStandard Deviation 14
Primary

Negative Affect

Negative affect will be assessed with the sadness, guilt, and fear/anxiety subscales (totaling 20 items) from the Positive Affect and Negative Affect Scale-Revised. Each item is scored on a scale of 1 = Not at All to 5 = Extremely. Item scores were averaged to create an overall score (1 to 5) Higher scores indicate greater negative affect.

Time frame: Week 6 (post-intervention) and three months following the 6-week intervention period

ArmMeasureGroupValue (MEAN)Dispersion
Diabetes Body ProjectNegative AffectPost Test (week 6)1.79 score on a scaleStandard Deviation 0.77
Diabetes Body ProjectNegative Affect3-Month Post Test Follow Up1.95 score on a scaleStandard Deviation 0.79
Educational Control GroupNegative AffectPost Test (week 6)2.01 score on a scaleStandard Deviation 0.64
Educational Control GroupNegative Affect3-Month Post Test Follow Up2.34 score on a scaleStandard Deviation 1.09
Primary

Percentage of Time With Blood Sugar in Range as a Measure of Glycemic Control

Participants wore a continuous-glucose monitor for 14 days as well as self-reported A1c levels. The percentage of time that participants had blood sugar in range (70 to 180 mg/dL) is reported.

Time frame: Three months following the 6-week intervention period

ArmMeasureValue (MEAN)Dispersion
Diabetes Body ProjectPercentage of Time With Blood Sugar in Range as a Measure of Glycemic Control0.61 percentage of timeStandard Deviation 0.2
Educational Control GroupPercentage of Time With Blood Sugar in Range as a Measure of Glycemic Control0.63 percentage of timeStandard Deviation 0.21
Primary

Quality of Life (Well-Being)

Assessed with the 5-item World Health Organization Well-Being Index that measures health related quality of life. Each item is scored on a scale of 0 = At no Time to 5 = All of the Time. Item scores were averaged to create an overall score (0 to 5). Higher scores indicate greater well-being.

Time frame: Week 6 (post-intervention) and three months following the 6-week intervention period

ArmMeasureGroupValue (MEAN)Dispersion
Diabetes Body ProjectQuality of Life (Well-Being)Post-Test (week 6)2.94 score on a scaleStandard Deviation 0.91
Diabetes Body ProjectQuality of Life (Well-Being)3-Month Post-Test Follow Up2.75 score on a scaleStandard Deviation 0.99
Educational Control GroupQuality of Life (Well-Being)Post-Test (week 6)2.55 score on a scaleStandard Deviation 0.88
Educational Control GroupQuality of Life (Well-Being)3-Month Post-Test Follow Up2.17 score on a scaleStandard Deviation 0.93
Primary

Thin Ideal Internalization

Assessed with the 8-item Ideal-Body Stereotype Scale-Revised which measures pursuit of the thin ideal. Each item is scored on a scale of 1 = strongly disagree to 5 = strongly agree. Item scores were averaged to create an overall score (1 to 5). Higher scores indicate greater belief in the thin-deal.

Time frame: Week 6 (post-intervention) and three months following the 6-week intervention period

ArmMeasureGroupValue (MEAN)Dispersion
Diabetes Body ProjectThin Ideal InternalizationPost-Test (week 6)2.92 score on a scaleStandard Deviation 0.75
Diabetes Body ProjectThin Ideal Internalization3-Month Post-Test Follow-Up3.12 score on a scaleStandard Deviation 0.71
Educational Control GroupThin Ideal InternalizationPost-Test (week 6)3.15 score on a scaleStandard Deviation 0.66
Educational Control GroupThin Ideal Internalization3-Month Post-Test Follow-Up3.10 score on a scaleStandard Deviation 0.65

Source: ClinicalTrials.gov · Data processed: Sep 15, 2026